Related Experiment Video

Updated: Jun 19, 2026

Spectrophotometric Screening for Potential Inhibitors of Cytosolic Glutathione S-Transferases
14:57

Spectrophotometric Screening for Potential Inhibitors of Cytosolic Glutathione S-Transferases

Published on: October 10, 2020

gamma-glutamyltransferase and pathogenesis of cardiovascular diseases

Michele Emdin1, Claudio Passino, Maria Franzini

  • 1CNR Institute of Clinical Physiology, Via G Moruzzi 1-56127 Pisa, Italy. emdin@ifc.cnr.it

Future Cardiology
|October 7, 2009
PubMed

Insights

Serum gamma-glutamyltransferase (GGT) is linked to increased cardiovascular risk, including stroke and heart attack. Further research is needed to understand why elevated GGT predicts poor outcomes in atherosclerosis.

Area of Science:

  • Cardiovascular Epidemiology
  • Biochemistry
  • Medical Diagnostics

Background:

  • Recent cardiovascular epidemiology studies show a strong association between serum gamma-glutamyltransferase (GGT) and adverse cardiovascular events.
  • Elevated serum GGT levels are linked to increased risk of stroke, infarction, and cardiovascular death.
  • These risks are often associated with the progression of atherosclerosis-related conditions like coronary artery and cerebrovascular disease.

Purpose of the Study:

  • To investigate the underlying reasons for the observed association between elevated serum GGT levels and unfavorable cardiovascular prognosis.
  • To explore the role of GGT as a cardiovascular prognostic marker.
  • To identify new research avenues for monitoring and treating chronic cardiovascular conditions based on GGT's role.

Main Methods:

  • Review of cardiovascular epidemiology data linking serum GGT to cardiovascular outcomes.
  • Analysis of histochemical and biochemical findings related to GGT.
  • Exploration of potential mechanisms connecting GGT to atherosclerosis and cardiovascular events.

Main Results:

  • Serum GGT is established as a significant cardiovascular prognostic marker.
  • A clear link exists between elevated serum GGT and increased risk of stroke, infarction, and cardiovascular death.
  • The precise biological mechanisms driving this association require further elucidation.

Conclusions:

  • Serum GGT is a recognized marker for cardiovascular risk, particularly in conditions like atherosclerosis.
  • Understanding the etiological basis of the GGT-cardiovascular link is crucial for refining prognostic assessments.
  • Further research into GGT's role may lead to improved strategies for managing chronic cardiovascular diseases.

More Related Videos

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform06:21

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform

Published on: May 10, 2024

Related Concept Videos

Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation01:22

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...